Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older
Clinical trial NCT05639894 · COMPLETED
Trial details
- NCT number
- NCT05639894
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-17
- Primary completion
- 2025-05-02
- Enrollment
- 865
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.